Somatic Mutation Theory - Why it's Wrong for Most Cancers

Hysteron proteron reverses both temporal and logical order and this syllogism occurs in carcinogenesis and the somatic mutation theory (SMT): the first (somatic mutation) occurs only after the second (onset of cancer) and, therefore, observed somatic mutations in most cancers appear well after the early cues of carcinogenesis are in place. It is no accident that mutations are increasingly being questioned as the causal event in the origin of the vast majority of cancers as clinical data show little support for this theory when compared against the metrics of patient outcomes. Ever since the discovery of the double helical structure of DNA, virtually all chronic diseases came to be viewed as causally linked to one degree or another to mutations, even though we now know that genes are not simply blueprints, but rather an assemblage of alphabets that can, under non-genetic influences, be used to assemble a business letter or a work of Shakespearean literature. A minority of all cancers is indeed caused by mutations but the SMT has been applied to all cancers, and even to chemical carcinogenesis, in the absence of hard evidence of causality. Herein, we review the 100 year story of SMT and aspects that show why genes are not just blueprints, how radiation and mutation are associated in a more nuanced view, the proposed risk of cancer and bad luck, and the in vitro and in vivo evidence for a new cancer paradigm. This paradigm is scientifically applicable for the majority of non-heritable cancers and consists of a six-step sequence for the origin of cancer. This new cancer paradigm proclaims that somatic mutations are epiphenomena or later events occurring after carcinogenesis is already underway. This serves not just as a plausible alternative to SMT and explains the origin of the majority of cancers, but also provides opportunities for early interventions and prevention of the onset of cancer as a disease.

[1]  Yi Zeng,et al.  Prevalence of human papillomavirus in esophageal carcinoma in Tangshan, China. , 2015, World journal of gastroenterology.

[2]  Christopher Lawrence,et al.  Medicine's 10 Greatest Discoveries , 1999, BMJ.

[3]  A. Avivi,et al.  Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitroevidence , 2013, BMC Biology.

[4]  Christopher M Overall,et al.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.

[5]  A. Morris,et al.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, BDJ.

[6]  M. Okumura,et al.  Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[7]  I. Jamall,et al.  Cell-Cell Communication in the Tumor Microenvironment, Carcinogenesis, and Anticancer Treatment , 2014, Cellular Physiology and Biochemistry.

[8]  Nordling Co A New Theory on the Cancer-inducing Mechanism , 1953 .

[9]  J. Cleaver,et al.  Xeroderma pigmentosum family support group: Helping families and promoting clinical initiatives. , 2011, DNA repair.

[10]  I. Jamall,et al.  Epistemology of the origin of cancer: a new paradigm , 2014, BMC Cancer.

[11]  B. Emerson,et al.  p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes , 2014, eLife.

[12]  L. Loeb,et al.  A mutator phenotype in cancer. , 2001, Cancer research.

[13]  Ulf Gyllensten,et al.  Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs , 2014, Nature Communications.

[14]  K. Schlessinger,et al.  GSK-3beta sets Snail's pace. , 2004, Nature cell biology.

[15]  A. Levitzki,et al.  Heterogeneity of Gene Expression in Murine Squamous Cell Carcinoma Development—The Same Tumor by Different Means , 2013, PloS one.

[16]  J. Pouysségur,et al.  Transforming Growth Factor 1 (TGF- 1) Promotes Endothelial Cell Survival during In Vitro Angiogenesis via an Autocrine Mechanism Implicating TGF- Signaling , 2001 .

[17]  Richard Van Noorden Interdisciplinary research by the numbers , 2015, Nature.

[18]  K. Schlessinger,et al.  GSK-3β sets Snail's pace , 2004, Nature Cell Biology.

[19]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Versteeg Cancer: Tumours outside the mutation box , 2014, Nature.

[21]  Xiaoyan Li,et al.  A Genetic Polymorphism (rs17251221) in the Calcium-Sensing Receptor is Associated with Breast Cancer Susceptibility and Prognosis , 2014, Cellular Physiology and Biochemistry.

[22]  N. Lu,et al.  Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. , 2011, Toxicology.

[23]  A. Wada,et al.  Human papillomavirus genotypes in penile cancers from Japanese patients and HPV-induced NF-κB activation. , 2010, Oncology letters.

[24]  K. Konstantopoulos,et al.  By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization , 2015, Oncotarget.

[25]  W. Bushman,et al.  Prostatic Inflammation Induces Fibrosis in a Mouse Model of Chronic Bacterial Infection , 2014, PloS one.

[26]  Theodor Boveri Zur Frage der Entstehung maligner Tumoren , 1914 .

[27]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[28]  P. Slocombe,et al.  The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 , 2000, FEBS letters.

[29]  Douglas A. Simonetto,et al.  Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. , 2014, Gastroenterology.

[30]  W. Blattner Human retroviruses: their role in cancer. , 1999, Proceedings of the Association of American Physicians.

[31]  M. Sekeres,et al.  The revolution of myelodysplastic syndromes , 2011, Therapeutic advances in hematology.

[32]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1974, Nature.

[33]  J. Woessner,et al.  Purification and properties of a small latent matrix metalloproteinase of the rat uterus. , 1988, The Journal of biological chemistry.

[34]  N. Bhamarapravati,et al.  Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. , 1978, Cancer research.

[35]  C. Sander,et al.  Genome-wide analysis of non-coding regulatory mutations in cancer , 2014, Nature Genetics.

[36]  H. Rammensee,et al.  Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells , 2008, Clinical Cancer Research.

[37]  E. Chargaff,et al.  Human Desoxypentose Nucleic Acid: Composition of Human Desoxypentose Nucleic Acid , 1950, Nature.

[38]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[39]  P. Henriet,et al.  Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. , 2012, Biochimica et biophysica acta.

[40]  D. Kraft,et al.  NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells , 2015, Leukemia.

[41]  M. Stratton,et al.  Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer , 2006, Genetics.

[42]  C. Lopes,et al.  Insight into the molecular basis of Schistosoma haematobium-induced bladder cancer through urine proteomics , 2016, Tumor Biology.

[43]  Shanmin Zhao,et al.  KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia , 2014, Cellular Physiology and Biochemistry.

[44]  Li Ding,et al.  C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma , 2014, Nature.

[45]  J. Fletcher,et al.  Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. , 2005, American journal of clinical pathology.

[46]  T. Chou,et al.  Prevalence of human papillomavirus in middle ear carcinoma associated with chronic otitis media. , 1997, The American journal of pathology.

[47]  R. Flavell,et al.  Spatial proximity of homologous alleles and long noncoding RNAs regulate a switch in allelic gene expression , 2015, Proceedings of the National Academy of Sciences.

[48]  P. Dijke,et al.  The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system , 2011, Breast Cancer Research and Treatment.

[49]  Gerhard Christofori,et al.  Mechanisms of Motility in Metastasizing Cells , 2010, Molecular Cancer Research.

[50]  M. Hallek,et al.  mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. , 2013, The Journal of clinical investigation.

[51]  Zhengqian Li,et al.  Curcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA- MB-231 cells. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[52]  Meilin Wang,et al.  Interaction Between IGF1 Polymorphisms and the Risk of Acute Lymphoblastic Leukemia in Chinese Children , 2015, Cellular Physiology and Biochemistry.

[53]  M. Joseph,et al.  Transforming Growth Factor-B1 Promotes Matrix Metalloproteinase-9–Mediated Oral Cancer Invasion through Snail Expression , 2008 .

[54]  F. Stelzner Botschaft des Genoms , 1999 .

[55]  Katsunori Yoshida,et al.  TGF-β/Smad signaling during hepatic fibro-carcinogenesis (Review) , 2014, International journal of oncology.

[56]  J. Noto,et al.  Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization , 2014, Oncogene.

[57]  Y. Oji,et al.  WT1 Enhances Proliferation and Impedes Apoptosis in KRAS Mutant NSCLC via Targeting cMyc , 2015, Cellular Physiology and Biochemistry.

[58]  E. Nevo,et al.  High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat , 2013 .

[59]  K. Mullis,et al.  Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. , 1986, Cold Spring Harbor symposia on quantitative biology.

[60]  L. Loeb,et al.  Environmental and chemical carcinogenesis. , 2004, Seminars in cancer biology.

[61]  David A. Eccles,et al.  Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. , 2015, Cell metabolism.

[62]  D. E. Discher,et al.  Matrix elasticity directs stem cell lineage — Soluble factors that limit osteogenesis , 2009 .

[63]  M. Okumura,et al.  Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[64]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[65]  B. Dewald,et al.  Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[66]  T. H. van der Kwast,et al.  Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial‐to‐mesenchymal transition (EMT) in bladder cancer , 2016, Molecular carcinogenesis.

[67]  S. Watson,et al.  Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7 , 2010, Gut.

[68]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[69]  L. Bardwell,et al.  Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[70]  T. Salo,et al.  MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas. , 2015, Oral surgery, oral medicine, oral pathology and oral radiology.

[71]  C. Begley,et al.  Drug development: Raise standards for preclinical cancer research , 2012, Nature.

[72]  T. Shimizu,et al.  Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells , 2010, British Journal of Cancer.

[73]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[74]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[75]  M. Okumura,et al.  Effect of low-dose human atrial natriuretic peptide on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer: a double-blind, placebo-controlled study. , 2012, Journal of Thoracic and Cardiovascular Surgery.

[76]  A. Puisieux,et al.  Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition , 2008, PloS one.

[77]  C. Sander,et al.  Evaluating cell lines as tumour models by comparison of genomic profiles , 2013, Nature Communications.

[78]  Ido D. Weiss,et al.  Inflammation‐induced hepatocellular carcinoma is dependent on CCR5 in mice , 2013, Hepatology.

[79]  A. Sitges-Serra Clinical guidelines at stake , 2014, Journal of Epidemiology & Community Health.

[80]  A. Krüger,et al.  Adenovirus‐mediated overexpression of tissue inhibitor of metalloproteinases‐1 in the liver: efficient protection against T‐cell lymphoma and colon carcinoma metastasis , 2004, The journal of gene medicine.

[81]  M. Whiteley,et al.  Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum , 2015, Proceedings of the National Academy of Sciences.

[82]  D. J. Ashley,et al.  The two "hit" and multiple "hit" theories of carcinogenesis. , 1969, British Journal of Cancer.

[83]  F. Behbod,et al.  Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins , 2014, BMC Cancer.

[84]  Bin Tean Teh,et al.  The Opisthorchis viverrini genome provides insights into life in the bile duct , 2014, Nature Communications.

[85]  M. Santiago,et al.  Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection , 2014, Proceedings of the National Academy of Sciences.

[86]  Gary D Bader,et al.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy , 2014, Nature.

[87]  T. Day,et al.  The implications of nongenetic inheritance for evolution in changing environments , 2011, Evolutionary applications.

[88]  D. Sabatini,et al.  Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. , 2007, Blood.

[89]  T. Lindahl Instability and decay of the primary structure of DNA , 1993, Nature.

[90]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[91]  B. Druker Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML , 2002, Oncogene.

[92]  C. Woodworth,et al.  Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[93]  Dmitry A. Gordenin,et al.  Hypermutation in human cancer genomes: footprints and mechanisms , 2014, Nature Reviews Cancer.

[94]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[95]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[96]  M. Sonobe,et al.  Chronic Lung Injury by Constitutive Expression of Activation-Induced Cytidine Deaminase Leads to Focal Mucous Cell Metaplasia and Cancer , 2015, PloS one.

[97]  P. Vincent,et al.  Rearrangement of adherens junctions by transforming growth factor-β1: role of contraction. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[98]  S. Erkeland,et al.  Retroviral insertion mutagenesis in mice as a comparative oncogenomics tool to identify disease genes in human leukemia. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[99]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[100]  A. Harf,et al.  Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment. , 1999, American journal of respiratory cell and molecular biology.

[101]  R. Brekken,et al.  CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. , 2015, Cancer letters.

[102]  A. Jackson,et al.  The mutation rate and cancer. , 1998, Genetics.

[103]  L. Villa,et al.  The role of inflammation in HPV carcinogenesis. , 2010, Carcinogenesis.

[104]  Marcel J T Reinders,et al.  Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis , 2014, Genome research.

[105]  J. Cleaver,et al.  DNA repair and replication in xeroderma pigmentosum and related disorders. , 1986, Basic life sciences.

[106]  J. Chen,et al.  Association of the 3 ′ UTR FOXO 3 a Polymorphism rs 4946936 with an Increased Risk of Childhood Acute Lymphoblastic Leukemia in a Chinese Population , 2014 .

[107]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[108]  R. Conolly,et al.  Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[109]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[110]  Frédéric Dayan,et al.  The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. , 2011, Cancer research.

[111]  Nancy Argüelles,et al.  Author ' s , 2008 .

[112]  J. Pouysségur,et al.  Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. , 2001, Molecular and cellular biology.

[113]  L. Gissmann,et al.  A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[114]  A. Karameris,et al.  Impact of HPV detection in colorectal adenocarcinoma: HPV protein and chromogenic in situ hybridization analysis based on tissue microarrays. , 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[115]  Yun-zhao Chen,et al.  Human Papillomavirus Infection Correlates with Inflammatory Stat3 Signaling Activity and IL-17 Level in Patients with Colorectal Cancer , 2015, PloS one.

[116]  M. Sworn Cancer. The Outlaw Cell , 1989 .

[117]  Lilong Zhang,et al.  TGF-β-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-β in HaCaT cells. , 2012, The international journal of biochemistry & cell biology.

[118]  I. Ng,et al.  Lysyl oxidase‐like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma , 2014, Hepatology.

[119]  K. Nakao,et al.  Natriuretic Peptide Signaling via Guanylyl Cyclase (GC)-A: An Endogenous Protective Mechanism of the Heart , 2009, Current cardiology reviews.

[120]  Frederick Sachs,et al.  Actin stress in cell reprogramming , 2014, Proceedings of the National Academy of Sciences.

[121]  J. Stringer,et al.  Embryonic stem cells and somatic cells differ in mutation frequency and type , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[122]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[123]  S. Wessler,et al.  p120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7. , 2008, Molecular biology of the cell.

[124]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[125]  Xu-wen Liu,et al.  Novel functions of TIMPs in cell signaling , 2006, Cancer and Metastasis Reviews.

[126]  K. Sung,et al.  TGF-beta1 induces the different expressions of lysyl oxidases and matrix metalloproteinases in anterior cruciate ligament and medial collateral ligament fibroblasts after mechanical injury. , 2013, Journal of biomechanics.

[127]  G. Park,et al.  The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways. , 2014, Investigative Ophthalmology and Visual Science.

[128]  M. Okumura,et al.  Effects of low-dose human atrial natriuretic peptide for preventing post-operative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[129]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[130]  Guangmei Yan,et al.  Inactivation of lysyl oxidase by β-aminopropionitrile inhibits hypoxia-induced invasion and migration of cervical cancer cells. , 2013, Oncology reports.

[131]  K. Burridge,et al.  P120 Catenin Regulates the Actin Cytoskeleton via Rho Family Gtpases , 2000, The Journal of cell biology.

[132]  Arnoud Sonnenberg,et al.  Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing , 2010, EMBO reports.

[133]  William Wheeler,et al.  Detectable clonal mosaicism and its relationship to aging and cancer , 2012, Nature Genetics.

[134]  Yifan Chen,et al.  Cited2 modulates TGF-β-mediated upregulation of MMP9 , 2006, Oncogene.

[135]  Isaiah J. Fidler,et al.  The challenge of targeting metastasis , 2015, Cancer and Metastasis Reviews.

[136]  Jun Fang,et al.  RETRACTED ARTICLE: Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13 , 2014, Tumor Biology.

[137]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[138]  K. Bauer Mutationstheorie der Geschwulst-Entstehung: Übergang von Körperzellen in Geschwulstzellen durch Gen-Änderung , 1928 .

[139]  D. Danielpour,et al.  Cited2 modulates TGF-beta-mediated upregulation of MMP9. , 2006, Oncogene.

[140]  C. Nordling A New Theory on the Cancer-inducing Mechanism , 1953, British Journal of Cancer.

[141]  Christopher M. Vockley,et al.  Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.

[142]  B. Qasim,et al.  Immunohistochemical Expression of Matrix Metalloproteinase-7 in Human Colorectal Adenomas Using Specified Automated Cellular Image Analysis System: A Clinicopathological Study , 2013, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[143]  Minghua Wu,et al.  An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers. , 2014, Molecular bioSystems.

[144]  M. Nowak,et al.  Only three driver gene mutations are required for the development of lung and colorectal cancers , 2014, Proceedings of the National Academy of Sciences.

[145]  H. Khorana,et al.  Studies on polynucleotides. XCVI. Repair replications of short synthetic DNA's as catalyzed by DNA polymerases. , 1971, Journal of molecular biology.

[146]  A. D. Hershey,et al.  INDEPENDENT FUNCTIONS OF VIRAL PROTEIN AND NUCLEIC ACID IN GROWTH OF BACTERIOPHAGE , 1952, The Journal of general physiology.

[147]  A. Hoffmann,et al.  Transgenerational effects of parental nutritional status on offspring development time, survival, fecundity, and sensitivity to zinc in Chironomus tepperi midges. , 2014, Ecotoxicology and environmental safety.

[148]  S. Constantinescu,et al.  Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility. , 2015, Cancer discovery.

[149]  N. Takahashi,et al.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. , 1998, The Journal of clinical investigation.

[150]  Mahandranauth A. Chetram,et al.  ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells. , 2011, Biochemical and biophysical research communications.

[151]  L. Banks,et al.  The role of inflammation in HPV infection of the Oesophagus , 2013, BMC Cancer.

[152]  B. Zilberstein,et al.  Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers , 2016, Clinical and Translational Medicine.

[153]  E. Bradley,et al.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. , 2008, Experimental cell research.

[154]  D. Absher,et al.  Non-heritable genetics of human disease: spotlight on post-zygotic genetic variation acquired during lifetime , 2012, Journal of Medical Genetics.

[155]  D. Sonakul,et al.  Hepatic carcinoma with opisthorchiasis. , 1978, The Southeast Asian journal of tropical medicine and public health.

[156]  J. Veltman,et al.  De novo mutations in human genetic disease , 2012, Nature Reviews Genetics.

[157]  A. Fabre,et al.  The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis. , 2012, The American journal of pathology.

[158]  S. Rosenfeld Are the Somatic Mutation and Tissue Organization Field Theories of Carcinogenesis Incompatible? , 2013, Cancer informatics.

[159]  Sung-Hoon Kim,et al.  Melatonin Sensitizes H1975 Non-Small-Cell Lung Cancer Cells Harboring a T790M-Targeted Epidermal Growth Factor Receptor Mutation to the Tyrosine Kinase Inhibitor Gefitinib , 2014, Cellular Physiology and Biochemistry.

[160]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[161]  Swneke D. Bailey,et al.  Human somatic cell mutagenesis creates genetically tractable sarcomas , 2014, Nature Genetics.

[162]  M. Tachibana Epigenetic regulation of mammalian sex determination. , 2015, The journal of medical investigation : JMI.

[163]  R. Franklin,et al.  Molecular Configuration in Sodium Thymonucleate , 1953, Nature.

[164]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[165]  Kan Zhai,et al.  Detection of Human Papillomavirus DNA in Patients with Breast Tumor in China , 2015, PloS one.

[166]  G. Weinstock,et al.  Shedding genomic light on Aristotle's lantern. , 2006, Developmental biology.

[167]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.